Categories Earnings, Health Care

Earnings Summary: Organon reports financial results for Q1 2024

Pharmaceutical company Organon & Co. (NYSE: OGN) has reported higher revenues and adjusted earnings for the first quarter of 2024.

  • First-quarter revenue was $1.62 billion, which is up 5% on a reported basis and 7% at constant currency
  • Women’s Health revenue increased by 11% and Biosimilars revenue climbed by 46%
  • Meanwhile, Established Brands revenue was flat on an as-reported basis during the quarter
  • Reported earnings per share and adjusted earnings per share were $0.78 and $1.22, respectively, during the three months
  • Net income came in at $201 million in the March quarter and adjusted EBITDA was $538 million
  • Gross margin was 59.0% on a reported basis and 62.1% on an adjusted basis in the first quarter
  • Adjusted EBITDA margin dropped to 33.2% in the first quarter from 33.7% last year

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

What to look for when CVS Health (CVS) reports Q3 earnings

Healthcare company CVS Health Corporation (NYSE: CVS) is all set to report earnings next week, with Wall Street expecting a mixed outcome. The company has been facing challenges in certain

eBay (EBAY): A few factors that helped drive growth in Q3 2024

Shares of eBay Inc. (NASDAQ: EBAY) stayed green on Friday. The stock has gained 32% year-to-date. The ecommerce leader delivered revenue and earnings growth for the third quarter of 2024,

CVX Earnings: Chevron reports lower revenue and profit for Q3 2024

Energy exploration company Chevron Corporation (NYSE: CVX) on Friday announced third-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation dropped to

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top